Former Zykia Therapeutics CMO Jianming Cai Joins VivaVision Biotech as Chief Medical Officer Amid HKEX IPO Filing

On November 12, VIVAVISION announced the appointment of Dr. James Cai as Chief Medical Officer. Dr. Cai will comprehensively lead the clinical and medical teams, overseeing product pipeline strategy, planning and operations of clinical programs, and contributing to the formulation of the company’s overall development strategy. Prior to joining VIVAVISION, Dr. Cai held senior executive positions and led clinical teams at several global pharmaceutical companies, including serving as Chief Medical Officer at Zhaoke Ophthalmology, Vice President and Medical Director of PPD Inc. in the Asia-Pacific region, and Vice President of MDCO in the Asia-Pacific region.